정형외과용 바이오소재 시장 규모, 점유율, 동향 분석 보고서 : 재료별, 용도별, 지역별, 부문별 예측(2024-2030년)

Orthopedic Biomaterials Market Size, Share & Trends Analysis Report By Material (Metal, Polymers, Ceramics & Bioactive Glass Biomaterials), By Application (Orthobiologics, Orthopedic Implants), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

정형외과용 바이오소재(Orthopedic Biomaterials) 시장 성장 및 동향 :

Grand View Research, Inc.의 최근 조사에 따르면 정형외과용 바이오소재 세계 시장 규모는 2030년까지 359억 달러에 달할 것으로 예상되고 있으며, 2024년부터 2030년까지의 CAGR은 7.5%로 성장할 것으로 예측됩니다.

정형외과 질환의 유병률 증가와 생체재료기술의 진보 등 몇 가지 중요한 요인들이 시장을 견인하고 있습니다. 고령화와 활동적인 라이프스타일로 인해 변형성 관절증이나 골절 등 근골격계 장애의 발생률이 상승하고 있으며, 정형외과용 바이오소재 수요를 크게 밀어 올리고 있습니다. 또한, 첨단 복합재료와 스마트 생체재료 개발 등 혁신은 정형외과용 임플란트 및 인공장비에서 이러한 재료의 성능과 통합을 강화하여 그 용도와 효과를 확대하고 있습니다.

2023년 HSE 보고서에 따르면 영국에서는 약 47만 3,000명의 노동자들이 일과 관련된 근골격계 장애(MSD)를 경험했으며, 그 결과 약 660만일의 노동일수가 손실되었습니다. 이러한 장애는 일과 관련된 질병 전체의 27%를 차지합니다. 최소 침습 수술 기술에 대한 관심이 높아지고 있다는 것도 시장 성장에 기여합니다. 생체 흡수성 재료 및 개선된 임플란트 코팅 등 침습성이 낮은 수술을 지원하는 정형외과용 생체재료는 회복 시간과 합병증을 줄일 수 있기 때문에 인기를 끌고 있습니다. 연구개발 투자 증가, 건강 관리 지출 증가, 정형외과 솔루션의 첨단 인식이 시장을 더욱 강화하고 역동적이고 빠르게 진화하는 분야가 되고 있습니다.

외상 환자 증가는 또한 정형외과용 바이오소재 수요를 밀어 올리고 있습니다. WHO가 2022년 6월 발표한 논문에 따르면 교통사고로 세계에서 약 130만명이 사망하고 약 2,000만-5,000만명이 치명적이지 않은 부상으로 고통받고 있습니다. 이러한 부상은 정형외과 수술을 필요로 하는 경우가 많으며, 정형외과용 바이오소재 수요 증가로 이어지고 있습니다.

정형외과용 바이오소재 시장 보고서 하이라이트

• 재료별로, 세라믹과 생체활성 유리 부문은 2023년에 가장 높은 매출 점유율을 차지했습니다. 이러한 성장은 다양한 치료에서 경질 조직의 복원에 세라믹 채택이 증가했기 때문입니다.
• 용도별로는 정형외과 임플란트 분야가 2023년 최대 시장 점유율을 차지했습니다. 이 성장은 외상이 증가함에 따라 퇴행성 추간판 질환과 골절의 발생률이 증가하고 있기 때문입니다.
• 2023년에는 북미가 36.2%의 매출 점유율로 전체 시장을 지배했습니다. 이는 골공극 충전 및 임플란트 하중 지지를 목적으로 하는 첨단 제품의 채택이 증가하고 있기 때문입니다.

목차

제1장 조사 방법 및 범위

제2장 주요 요약

제3장 정형외과용 바이오소재 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 정형외과용 바이오소재 시장 분석 툴
  • 업계 분석-Porter's Five Forces 분석
  • PESTEL 분석

제4장 정형외과용 바이오소재 시장 : 재료별 추정·동향 분석

• 재료별 대시보드
• 정형외과용 바이오소재 시장 : 재료 변동 분석
• 정형외과용 바이오소재 시장 : 재료별 전망
• 시장 규모 및 예측, 동향 분석(2018-2030년)
• 세라믹과 생체 활성 유리
• 폴리머 생체 재료
• 인산칼슘 시멘트
• 금속 바이오소재
• 복합재료

제5장 정형외과용 바이오소재 시장 : 용도별 추정·동향 분석

• 용도별 대시보드
• 정형외과용 바이오소재 시장 : 용도 변동 분석
• 정형외과용 바이오소재 시장 : 용도별 전망
• 시장 규모 및 예측, 동향 분석(2018-2030년)
• 정형외과용 임플란트
• 관절 치환·재건
• 정형생물학(Orthobiologics)
• 점성 보충제
• 생체 흡수성 조직 고정

제6장 정형외과용 바이오소재 시장 : 지역별 추정·동향 분석

• 지역 대시보드
• 정형외과용 바이오소재 시장 : 지역별 변동 분석
• 정형외과용 바이오소재 시장 : 지역별 추정·동향 분석
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아 태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 남미
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 시장 진출기업 분류
• 주요 기업 프로파일
  • DSM Biomedical
  • Evonik industries AG
  • Stryker Corp
  • Depuy Synthes Inc
  • Zimmer Biomet
  • Invibo Ltd.
  • Globus Medical
  • . Exactech, Inc.
  • Matexcel
  • AdvanSource
  • Biomaterials Corp
  • CAM Bioceramics BV
  • Heraeus Holding

LYJ

영문 목차

영문목차

Orthopedic Biomaterials Market Growth & Trends:

The global orthopedic biomaterials market size is expected to reach USD 35.90 billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030, according to a new study by Grand View Research, Inc. Several key factors, including the increasing prevalence of orthopedic conditions and advancements in biomaterial technology, drive the market. Due to an aging population and active lifestyles, the rising incidence of musculoskeletal disorders, such as osteoarthritis and fractures, is significantly boosting the demand for orthopedic biomaterials. Moreover, technological innovations, such as the development of advanced composites and smart biomaterials, enhance the performance and integration of these materials in orthopedic implants and prosthetics, thereby expanding their application and effectiveness.

The increasing prevalence of musculoskeletal disorders and chronic skeletal conditions is fueling the market growth.According to the 2023 HSE Report, approximately 473,000 workers in Great Britain experienced work-related musculoskeletal disorders (MSDs), resulting in the loss of around 6.6 million working days. These disorders accounted for 27% of all work-related ill health cases. The growing focus on minimally invasive surgical techniques also contributes to market growth. Orthopedic biomaterials that support less invasive procedures, such as bioresorbable materials and improved implant coatings, are gaining traction due to their potential to reduce recovery times and complications. The increased investment in research and development, rising healthcare expenditures, and awareness about advanced orthopedic solutions further propels the market, making it a dynamic and rapidly evolving sector.

The rising prevalence of trauma cases is also driving the demand for orthopedic biomaterials. According to an article published by WHO in June 2022, road accidents kill approximately 1.3 million people worldwide, and approximately 20 to 50 million people suffer from non-fatal injuries. These injuries often require orthopedic surgery, leading to an increased demand for orthopedic biomaterials.

Orthopedic Biomaterials Market Report Highlights:

• By material, ceramics & bioactive glass segment accounted for the highest revenue share in 2023. The growth is attributed to the increased adoption of ceramics in the repair of hard tissues in various procedures
• By application, orthopedic implants segment accounted for the largest market share in 2023. The growth is owed to the rising incidences of disc degenerative conditions and bone fractures coupled with increasing trauma case
• In 2023, North America dominated the overall market with a revenue share of 36.2% due to the rising adoption of advanced products for bone void filling and implant load-bearing purposes

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Material
  • 1.2.2. Application
  • 1.2.3. Regional Scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Material outlook
  • 2.2.2. Application outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Orthopedic Biomaterials Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Orthopedic Biomaterials Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Orthopedic Biomaterials Market: Material Estimates & Trend Analysis

• 4.1. Material Segment Dashboard
• 4.2. Orthopedic Biomaterials Market: Material Movement Analysis
• 4.3. Orthopedic Biomaterials Market by Material Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Ceramics & Bioactive Glass Biomaterials
  • 4.5.1. Ceramics & Bioactive Glass Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Polymers Biomaterials
  • 4.6.1. Polymers Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Calcium Phosphate Cements
  • 4.7.1. Calcium Phosphate Cements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Metal Biomaterials
  • 4.8.1. Metal Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. Composites
  • 4.9.1. Composites Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Orthopedic Biomaterials Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Orthopedic Biomaterials Market: Application Movement Analysis
• 5.3. Orthopedic Biomaterials Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Orthopedic Implants
  • 5.5.1. Orthopedic Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Joint Replacement/reconstruction
  • 5.6.1. Joint Replacement/Reconstruction Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Orthobiologics
  • 5.7.1. Orthobiologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Visco Supplementation
  • 5.8.1. Visco Supplementation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Bio-resorbable Tissue Fixation
  • 5.9.1. Bio-resorbable Tissue Fixation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million

Chapter 6. Orthopedic Biomaterials Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Orthopedic Biomaterials Market Movement Analysis
• 6.3. Orthopedic Biomaterials Market: Regional Estimates & Trend Analysis by Material and Applications
• 6.4. North America
  • 6.4.1. North America Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. U.S. Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. Canada Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. Mexico Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. UK Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Germany Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. France Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Competitive Scenario
    • 6.5.5.3. Regulatory Framework
    • 6.5.5.4. Italy Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Competitive Scenario
    • 6.5.6.3. Regulatory Framework
    • 6.5.6.4. Spain Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Norway
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Norway Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Sweden
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Competitive Scenario
    • 6.5.8.3. Regulatory Framework
    • 6.5.8.4. Sweden Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Denmark
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Competitive Scenario
    • 6.5.9.3. Regulatory Framework
    • 6.5.9.4. Denmark Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Japan Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. China Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. India Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. South Korea Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Australia Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Thailand Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Brazil Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Argentina Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Middle East & Africa
  • 6.8.1. Middle East & Africa Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. South Africa Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Saudi Arabia Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. UAE Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Kuwait Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. DSM Biomedical
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Evonik industries AG
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. Stryker Corp
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Depuy Synthes Inc
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Zimmer Biomet
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Invibo Ltd.
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Globus Medical
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. . Exactech, Inc.
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. Matexcel
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. AdvanSource
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives
  • 7.2.11. Biomaterials Corp
    • 7.2.11.1. Company overview
    • 7.2.11.2. Financial performance
    • 7.2.11.3. Product benchmarking
    • 7.2.11.4. Strategic initiatives
  • 7.2.12. CAM Bioceramics B.V.
    • 7.2.12.1. Company overview
    • 7.2.12.2. Financial performance
    • 7.2.12.3. Product benchmarking
    • 7.2.12.4. Strategic initiatives
  • 7.2.13. Heraeus Holding
    • 7.2.13.1. Company overview
    • 7.2.13.2. Financial performance
    • 7.2.13.3. Product benchmarking
    • 7.2.13.4. Strategic initiatives

관련자료